Marsico Capital Management’s Amgen AMGN Stock Holding History

Marsico Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-49,623	Closed	-$8.46M	–	84
2018 Q1	$8.46M	Sell	49,623 -42,723	-46%	-$7.84M	0.32%	36
2017 Q4	$16.1M	Sell	92,346 -29,350	-24%	-$5.19M	0.64%	23
2017 Q3	$22.7M	Sell	121,696 -11,899	-9%	-$2.11M	0.91%	23
2017 Q2	$23M	Hold	133,595	–	–	0.96%	25
2017 Q1	$21.9M	Sell	133,595 -28,981	-18%	-$4.82M	0.95%	28
2016 Q4	$23.8M	Sell	162,576 -13,227	-8%	-$1.99M	1.05%	23
2016 Q3	$29.3M	Sell	175,803 -12,789	-7%	-$2.16M	1.1%	25
2016 Q2	$28.7M	Sell	188,592 -3,194	-2%	-$497K	1%	24
2016 Q1	$28.8M	Sell	191,786 -432,490	-69%	-$64.3M	0.85%	24
2015 Q4	$101M	Buy	+624,276	New	+$98.1M	1.79%	21

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marsico Capital Management's AMGN Position: Q2 2018 in Review

Marsico Capital Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 49,623 shares — an estimated $8.46M sold.

Marsico Capital Management first reported a position in AMGN in Q4 2015 and held it in 10 quarters. The position peaked at $101M in Q4 2015. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

Marsico Capital Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
Marsico Capital Management sold 49,623 Amgen shares in Q2 2018, an estimated $8.46M.
Marsico Capital Management first reported a position in Amgen in Q4 2015 and held it in 10 quarters.
Marsico Capital Management's Amgen position peaked at $101M in Q4 2015.
1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Marsico Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.